Skip to main content

Table 3 Activity schedule for phase II clinical trial in acute leukemias

From: Exploring the safety and efficacy of phytomedicine Petiveria alliacea extract (Esperanza) in patients with metastatic gastrointestinal tumors and acute leukemias: study protocol for a phase Ib/randomized double blind phase II trial (PA001)

Schedule of activities

Acute leukemias

 

Enrollment

Initial Visit and chemotherapy cycle 1

Cycle 2

Close-outa

Time point

Week 1

Week 2

Week 6

Week 10

Enrolment

 Screening and Informed Consent

X

   

 Physical Examen

 

X

X

X

 Clinical Record

 

X

X

X

 HIV Test and Pregnancy test

X

   

Interventions

 Medication dispensing

 

X

X

X

 Follow-up visit

 

X

X

X

Safety Assessment

 Hemogram

 

X

 

X

 Transaminase AST

 

X

 

X

 Transaminase ALT

 

X

 

X

 Alkaline Phosphatase

 

X

 

X

 Total Bilirubin

 

X

 

X

 Triglycerides

 

X

 

X

 Total Cholesterol

 

X

 

X

 Blood Urea Nitrogen (BUN)

 

X

 

X

 Creatinine

 

X

 

X

 Urinalysis

 

X

 

X

 Uric Acid

 

X

 

X

 LDH (Lactate Dehydrogenase)

 

X

 

X

 Lactic Acid

 

X

 

X

 Ferritin

 

X

 

X

 Albumin

 

X

 

X

 Iron

 

X

 

X

 Electrocardiogram

 

X

 

X

 Echocardiogram

 

X

 

X

Efficacy Assessment

 Myelogram and flow cytometry

 

X

 

X

 Tumor Antigens

 

X

 

X

 Metabolome

 

X

 

X

 Microbiome Analysis

 

X

 

X

 Proinflammatory Cytokines

 

X

 

X

 Circulating DNA

 

X

 

X

 Ketone Bodies

 

X

 

X

 Tumor Infiltration

 

X

 

X

 QLQ C-30 Quality of Life Surveys

 

X

X

X

 Progression-Free Survival

 

X

 

X

  1. aFor new diagnosis the intervention will be only in induction chemotherapy cycle with the close out visit in week 6